Medicare Enrolled
Dr. Neil Mushlin, D.O.
Pulmonary Disease · Lansdale, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mushlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mushlin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mushlin
Dr. Neil Mushlin is a pulmonary disease specialist in Lansdale, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mushlin performed 9,732 Medicare services across 4,503 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mushlin received a total of $357,584 from 59 pharmaceutical and/or device companies across 2939 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mushlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in PA
$357,584 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,732
Medicare services
Top 1% in PA for pulmonary disease
4,503
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~512 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
3,537 | $37 | $167 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,147 | $99 | $426 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
1,018 | $118 | $573 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
563 | $68 | $310 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
394 | $31 | $201 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
393 | $36 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
390 | $46 | $205 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
390 | $127 | $549 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
231 | $38 | $216 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
176 | $39 | $184 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
88 | $15 | $59 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
84 | $27 | $111 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
70 | $82 | $370 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
64 | $34 | $283 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
46 | $375 | $1,574 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $135 | $593 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
25 | $96 | $2,215 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
24 | $21 | $84 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
24 | $715 | $2,453 |
| New patient office visit, complex (60-74 min) | 23 | $171 | $724 |
| Home sleep study test with type II portable monitor An unattended sleep study performed at home using a portable monitor that records at least seven channels, including brain activity, eye movement, muscle activity, heart rate, airflow, breathing effort, and oxygen levels. |
14 | $82 | $234 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$357,584
Total received (2018-2024)
Avg $51,083/year across 7 years
Top 2% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
2,939
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$268,877 (75.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,251 (16.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,456 (8.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$38,992
2023
$29,144
2022
$72,229
2021
$108,375
2020
$27,963
2019
$49,261
2018
$31,619
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$16,160
JAZZ PHARMACEUTICALS INC.
$15,766
Optinose US, Inc.
$1,154
GlaxoSmithKline, LLC.
$1,043
Avadel CNS Pharmaceuticals, LLC
$555
Axsome Therapeutics, Inc.
$533
Mallinckrodt Hospital Products Inc.
$495
Amgen Inc.
$443
HARMONY BIOSCIENCES LLC
$388
Mylan Specialty L.P.
$360
Paratek Pharmaceuticals, Inc.
$306
Novartis Pharmaceuticals Corporation
$278
Baxter Healthcare
$274
Harmony Biosciences Llc
$163
Inspire Medical Systems, Inc.
$155
Insmed, Inc.
$152
Genentech USA, Inc.
$134
Grifols USA, LLC
$114
United Therapeutics Corporation
$96
Electromed, Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
PFIZER INC.
$57
Regeneron Healthcare Solutions, Inc.
$31
Philips North America LLC
$30
Resmed Corp
$25
Vifor Pharma, Inc.
$24
Tactile Systems Technology Inc
$24
ANI Pharmaceuticals, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$17
GENZYME CORPORATION
$16
3B Medical, Inc.
$14
Top 3 companies account for 84.8% of 2024 payments
All-time payments by company (2018-2024) ›
Advanced Respiratory, Inc
$69,427
Baxter Healthcare
$43,397
AstraZeneca Pharmaceuticals LP
$41,643
JAZZ PHARMACEUTICALS INC.
$38,687
Mallinckrodt Hospital Products Inc.
$32,498
Genentech USA, Inc.
$27,495
Grifols USA, LLC
$19,460
Mallinckrodt Enterprises LLC
$18,085
Harmony Biosciences LLC
$15,598
HARMONY BIOSCIENCES LLC
$9,242
Jazz Pharmaceuticals Inc.
$6,769
GlaxoSmithKline, LLC.
$6,120
Sunovion Pharmaceuticals Inc.
$4,684
Regeneron Healthcare Solutions, Inc.
$3,402
Philips Electronics North America Corporation
$2,956
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,287
Amgen Inc.
$1,889
Mylan Specialty L.P.
$1,816
Novartis Pharmaceuticals Corporation
$1,531
Axsome Therapeutics, Inc.
$1,509
Optinose US, Inc.
$1,366
Grifols Shared Services North America, Inc.
$820
ARBOR PHARMACEUTICALS, INC.
$744
Actelion Pharmaceuticals US, Inc.
$725
Inspire Medical Systems, Inc.
$705
Avadel CNS Pharmaceuticals, LLC
$595
ZOLL Respicardia, Inc.
$548
GENZYME CORPORATION
$427
Teva Pharmaceuticals USA, Inc.
$394
Insmed, Inc.
$378
Paratek Pharmaceuticals, Inc.
$373
ANI Pharmaceuticals, Inc.
$264
United Therapeutics Corporation
$200
OptiNose US, Inc.
$171
Harmony Biosciences Llc
$163
Mallinckrodt LLC
$141
Arbor Pharmaceuticals, Inc.
$129
Resmed Corp
$122
Electromed, Inc.
$116
Kaleo, Inc.
$95
PFIZER INC.
$82
kaleo, Inc.
$80
Exeltis, USA Inc.
$71
Genentech, Inc.
$54
Circassia Pharmaceuticals Inc
$45
ADVANCED RESPIRATORY, INC
$31
Philips North America LLC
$30
Phadia US Inc.
$29
CSL Behring
$27
Vifor Pharma, Inc.
$24
Tactile Systems Technology Inc
$24
Nabriva Therapeutics, plc
$17
Inogen, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
ViiV Healthcare Company
$14
Itamar Medical Inc
$14
3B Medical, Inc.
$14
Vapotherm Inc
$13
Top 3 companies account for 43.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AirCurve · AirDuo Digihaler · AirFit · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Edarbi · Esbriet · Evekeo · Evekeo ODT · FARXIGA · FASENRA · Flexitouch Plus · Hillrom - Life 2000 Ventilation System · Hillrom - Synclara Cough System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · Inspire Upper Airway Stimulation System · JULUCA · LATUDA · LONHALA MAGNAIR · LUMIZYME · LUMRYZ · LUNA · Life 2000 Ventilation System · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PAXLOVID · POMPE - DISEASE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · S&RC Und · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · SynclaraCough System · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The MetaNeb System · The Monarch Airway Clearance System · The Vest System 205 Acute Care · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · Utibron · Volara System · WAKIX · Wakix · WatchPAT · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xenleta · Xhance · Xofluza · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in PA.
Geographic Context
Pulmonary diseases within 10 mi
234
Per 100K population
27.2
County median income
$111,521
Nearest hospital
JEFFERSON LANSDALE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mushlin is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with speaking/promotional industry engagement in the top 2% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mushlin experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Mushlin performed 3,537 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mushlin receive payments from pharmaceutical companies?
Yes. Dr. Mushlin received a total of $357,584 from 59 companies across 2,939 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mushlin's costs compare to other pulmonary diseases in Lansdale?
Dr. Mushlin's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mushlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Lansdale
Browse pulmonary diseases in Lansdale ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
Advanced Respiratory, Inc Payments to Doctors
See all physicians who received payments from Advanced Respiratory, Inc.
By company
Baxter Healthcare Payments to Doctors
See all physicians who received payments from Baxter Healthcare.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology